- Home
- FINS vs AGL Comparison
FINS vs AGL Comparison
Compare FINS & AGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FINS | AGL |
|---|---|---|
| Founded | N/A | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Managed Health Care |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 436.4M | 422.9M |
| IPO Year | 2018 | 2021 |
Fundamental Metrics
Financial Performance| Metric | FINS | AGL |
|---|---|---|
| Price | $12.86 | $0.57 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 14 |
| Target Price | N/A | ★ $2.66 |
| AVG Volume (30 Days) | 80.7K | ★ 8.7M |
| Earning Date | 01-01-0001 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $5,932,576,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $7.17 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.21 | $0.34 |
| 52 Week High | $13.64 | $6.08 |
Technical Indicators
Market Signals| Indicator | FINS | AGL |
|---|---|---|
| Relative Strength Index (RSI) | 22.26 | 48.12 |
| Support Level | $12.84 | $0.51 |
| Resistance Level | $13.26 | $0.73 |
| Average True Range (ATR) | 0.10 | 0.08 |
| MACD | -0.04 | 0.03 |
| Stochastic Oscillator | 6.67 | 58.32 |
Price Performance
Historical ComparisonAbout FINS Angel Oak Financial Strategies Income Term Trust of Beneficial Interest
Angel Oak Financial Strats Income Term is a non-diversified, closed-end management investment company. The fund's objective is to seek current income with a secondary objective of total return. In pursuing its investment objective, the fund invests mainly in debt issued by financial institutions, including subordinated debt, unrated debt, senior debt, and high-yield securities.
About AGL agilon health inc.
Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.